v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Sep. 30, 2025
Current assets:    
Cash and cash equivalents $ 20,272 $ 32,298
Short-term marketable securities 174,241 156,566
Accounts receivable 5,855 6,882
Prepaid expenses and other current assets 5,626 8,590
Total current assets 205,994 204,336
Property and equipment, net 30,858 35,395
Operating lease, right-of-use assets 35,249 37,549
Long-term restricted cash 3,360 3,360
Other long-term assets 116 92
Total assets 275,577 280,732
Current liabilities:    
Accounts payable 2,750 1,948
Accrued expenses and other current liabilities 14,685 12,751
Liability related to the sale of future royalties 32,968 30,710
Operating lease liabilities 4,057 3,146
Total current liabilities 54,460 48,555
Liability related to the sale of future royalties, net of current portion 88,637 111,132
Operating lease liabilities, net of current portion 50,700 54,757
Series 1 nonconvertible preferred stock 1,290 1,311
Other long-term liabilities 295 260
Total liabilities 195,382 216,015
Commitments and contingencies (Note 13)
Stockholders' equity:    
Common stock; $0.01 par value per share, 100,000 shares authorized; 29,142 and 21,387 shares issued and outstanding at September 30, 2026 and September 30, 2025, respectively 291 214
Additional paid-in capital 554,064 469,771
Accumulated other comprehensive loss (983) (339)
Accumulated deficit (473,177) (404,929)
Total stockholders' equity 80,195 64,717
Total liabilities and stockholders' equity $ 275,577 $ 280,732